BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8308697)

  • 1. Effects of insulin and acarbose alone and in combination in the female streptozotocin-induced diabetic rat.
    Katovich MJ; Meldrum MJ
    J Pharm Sci; 1993 Dec; 82(12):1209-13. PubMed ID: 8308697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial effects of dietary acarbose in the streptozotocin-induced diabetic rat.
    Katovich MJ; Meldrum MJ; Vasselli JR
    Metabolism; 1991 Dec; 40(12):1275-82. PubMed ID: 1961120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effects of acarbose in the diabetic rat are not altered by feeding schedule.
    Wright BE; Vasselli JR; Katovich MJ
    Physiol Behav; 1998 Mar; 63(5):867-74. PubMed ID: 9618010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term treatment with insulin and/or acarbose on glomerular basement membrane thickening in alloxan-diabetic rats.
    Macedo CS; Silva MD; Spadella CT; Breim LC; Capeletti S; Mercadante MC; Hernandes D; Macedo AR
    Braz J Med Biol Res; 1996 Oct; 29(10):1329-35. PubMed ID: 9181105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic effects of acarbose in normal and diabetic rats: long- and short-term administration.
    Hess ME; Haugaard N; Min W; Torbati A
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):163-76. PubMed ID: 3800510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combined inositol hexakisphosphate and inositol supplement in streptozotocin-induced type 2 diabetic rats.
    Foster SR; Omoruyi FO; Bustamante J; Lindo RL; Dilworth LL
    Int J Exp Pathol; 2016 Oct; 97(5):397-407. PubMed ID: 27921351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acarbose treatment and diabetic nephropathy in the Cohen diabetic rat.
    Cohen AM; Rosenmann E
    Horm Metab Res; 1990 Oct; 22(10):511-5. PubMed ID: 2079312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of an alpha-glucosidase inhibitor on glomerular basement membrane anionic sites in streptozotocin induced mildly diabetic rats.
    Sato H; Shiina N
    Diabetes Res Clin Pract; 1997 Aug; 37(2):91-9. PubMed ID: 9279479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an alpha-glucosidase inhibitor.
    Takagi C; King GL; Clermont AC; Cummins DR; Takagi H; Bursell SE
    Curr Eye Res; 1995 Sep; 14(9):741-9. PubMed ID: 8529412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an alpha-glucosidase inhibitor, acarbose, on blood glucose and serum lipids in streptozotocin-induced diabetic rats.
    Yamashita K; Sugawara S; Sakairi I
    Horm Metab Res; 1984 Apr; 16(4):179-82. PubMed ID: 6373545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of acarbose (BAY-g-5421) on expression of noninsulin-dependent diabetes mellitus in sucrose-fed SHR/N-corpulent rats.
    Carswell N; Michaelis OE; Prather ES
    J Nutr; 1989 Mar; 119(3):388-94. PubMed ID: 2646401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of insulin on the altered thyroid function and adrenergic responsiveness in the diabetic rat.
    Katovich MJ; Marks KS; Sninsky CA
    Can J Physiol Pharmacol; 1993 Aug; 71(8):568-75. PubMed ID: 8306194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with acarbose may improve endothelial dysfunction in streptozotocin-induced diabetic rats.
    Vallejo S; Angulo J; Peiró C; Cercas E; Sánchez-Ferrer A; Nevado J; Llergo JL; Rodríguez-Mañas L; Sánchez-Ferrer CF
    J Cardiovasc Pharmacol; 2000 Aug; 36(2):255-62. PubMed ID: 10942169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic abnormalities in the genetically obese and diabetic Otsuka Long-Evans Tokushima Fatty rat can be prevented and reversed by alpha-glucosidase inhibitor.
    Yamamoto M; Jia DM; Fukumitsu KI; Imoto I; Kihara Y; Hirohata Y; Otsuki M
    Metabolism; 1999 Mar; 48(3):347-54. PubMed ID: 10094112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of alpha-glucosidase inhibition in the management of diabetes.
    Bischoff H
    Clin Invest Med; 1995 Aug; 18(4):303-11. PubMed ID: 8549017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of acarbose and miglitol (BAY-M-1099) on postprandial glucose levels following ingestion of various sources of starch by nondiabetic and streptozotocin-induced diabetic rats.
    Madar Z
    J Nutr; 1989 Dec; 119(12):2023-9. PubMed ID: 2695605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of alpha-glucosidase inhibition.
    Bischoff H
    Eur J Clin Invest; 1994 Aug; 24 Suppl 3():3-10. PubMed ID: 8001624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-meal coagulation activation in diabetes mellitus: the effect of acarbose.
    Ceriello A; Taboga C; Tonutti L; Giacomello R; Stel L; Motz E; Pirisi M
    Diabetologia; 1996 Apr; 39(4):469-73. PubMed ID: 8777997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acarbose partially prevents the development of diabetes mellitus by multiple low-dose streptozotocin administration.
    Negishi M; Shimizu H; Ohtani K; Mori M
    Diabetes Res Clin Pract; 1996 Jun; 33(1):15-9. PubMed ID: 8877271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative weight of glucose, insulin and parathyroid hormone in the urinary loss of phosphate by chronically diabetic rats.
    Locatto ME; Di Loreto V; Fernández MC; Caferra D; Puche RC
    Acta Diabetol; 1997 Oct; 34(3):211-6. PubMed ID: 9401643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.